课题基金 / 基金详情

Zytokin-vermitteltes Targeting von Adenovirusvektoren zur effizienten Transduktion hematopoietischer Zellen

Zytokin-vermitteltes Targeting von Adenovirusvektoren zur effizienten Transduktion hematopoietischer Zellen
细胞因子介导的腺病毒载体靶向用于造血细胞的有效转导
批准号:
22711144
负责人:
Professor Dr. Florian Kreppel
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2006
资助国家:
德国
项目状态:
已结题
起止时间:
2005-12-31 至 2012-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Adenovirus (Ad) vector targeting aims for the efficient gene transfer to specific cell types and tissues. So far, targeting efforts have met with limited success. Recently, we developed a novel geneti-chemical targeting platform that allows for the flexible use of different ligands even in combination with polymer shielding for the generation of truly retargeted Ad particles. However, our data indicate that not only the type of ligand, but also its position on the capsid strongly influences the intracellular fate of the vector particle and, therefore, transduction efficiency. This is probably due to post-receptor restrictions at the level of particle disassembly and/or particle trafficking. We will use the geneti-chemical targeting platform to characterize post-receptor restrictions for Ad vectors at the molecular and cell biology level. We will analyze the influence of ligand positioning and ligand copy number for three ligands with different intracellular fates: transferrin, EGF, and mannans. In addition, the influence of shielding polymers on the post-receptor fate of Ad vector particles will be characterized. Further, we will investigate the effect of bioresponsive bonds on post-receptor fate when used to link ligands and shielding polymers to the vector particles. Detailed analysis at a molecular level may form a basis for rational design of targeted Ad vectors. The results obtained may likely be transferable to other gene delivery systems.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/jgm.1262
发表时间: 2008-12
期刊: The Journal of Gene Medicine
影响因子: --
作者: [Sigrid Espenlaub;Andreas Wortmann;T. Engler;S. Corjon;S. Kochanek;F. Kreppel]
通讯作者: Sigrid Espenlaub;Andreas Wortmann;T. Engler;S. Corjon;S. Kochanek;F. Kreppel
DOI: 10.1021/mp300366f
发表时间: 2013-01
期刊: Molecular pharmaceutics
影响因子: 4.9
作者: [Alexandra Vetter;K. Virdi;Sigrid Espenlaub;W. Rödl;E. Wagner;P. Holm;C. Scheu;F. Kreppel;C. Spitzweg;M. Ogris]
通讯作者: Alexandra Vetter;K. Virdi;Sigrid Espenlaub;W. Rödl;E. Wagner;P. Holm;C. Scheu;F. Kreppel;C. Spitzweg;M. Ogris
海外基金